Transition probability calculations for atoms using nonorthogonal orbitals.

Jeppe Olsen,M. Godefroid,Per Jönsson,P. Malmqvist,C. F. Fischer

DOI: https://doi.org/10.1103/PHYSREVE.52.4499

1995-10-01

Abstract:

What problem does this paper attempt to address?

Elastic Stiffness of the Nuclear-Spin System in Tetragonal U 2 D 2 Nuclear-Ordered Solid 3

M. Yamaguchi,S. Sasaki,S. G. Lee,Y. Sasaki,T. Mizusaki

Abstract:
"Trust Me, I'm a Doctor." How TikTok Videos from Different Sources Influence Clinical Trial Participation

Yoorim Hong,Namyeon Lee,Ciera E. Kirkpatrick,Sisi Hu,Sungkyoung Lee,Amanda Hinnant

DOI: https://doi.org/10.1080/10410236.2024.2346680

IF: 3.501

2024-05-04

Health Communication

Abstract:This study experiments with TikTok videos to promote clinical trial participation. More specifically, it examines how short-form video sources (doctors vs. prior volunteers for clinical trials) influence perceived source credibility, self-efficacy, and behavioral intention to participate in clinical trials. Findings from this online experiment ( N = 396) showed that doctor sources led to greater behavioral intention through enhancing source credibility compared to prior volunteer sources. Alternatively, prior volunteer sources increased behavioral intention via enhanced self-efficacy for participants with low trust in doctors. These findings contribute to the understanding of how short-form video sources act as heuristic cues, leading to persuasion outcomes. Overall, we recommend featuring doctors when using video-based messages to promote clinical trial participation. Also, this study emphasizes the need for health communication practitioners to consider prior volunteers as spokespersons when targeting populations with low baseline trust in doctors.

health policy & services,communication
A Peer-Led Social Media Intervention to Improve Interest in Research Careers Among Urban Youth: Mixed Methods Study

Christianah Ogunleye,Jeanne M Farnan,Shannon K Martin,Audrey Tanksley,Samantha Ngooi,Laura Ruth Venable,Samantha Anderson,Jhonatan Marte,David O Meltzer,Vineet M Arora

DOI: https://doi.org/10.2196/16392

2020-05-14

Abstract:Background: Novel methods to boost interest in scientific research careers among minority youth are largely unexplored. Social media offers a unique avenue toward influencing teen behavior and attitudes, and can therefore be utilized to stimulate interest in clinical research. Objective: The aim of this study was to engage high-achieving minority youth enrolled in a science pipeline program to develop a targeted social media marketing campaign for boosting interest in clinical research careers among their peers. Methods: Students enrolled in the Training Early Achievers for Careers in Health program conducted focus groups in their communities to inform themes that best promote clinical research. They then scripted, storyboarded, and filmed a short video to share on social media with a campaign hashtag. Additionally, each student enrolled peers from their social circle to be subjects of the study. Subjects were sent a Career Orientation Survey at baseline to assess preliminary interest in clinical research careers and again after the campaign to assess how they saw the video, their perceptions of the video, and interest in clinical research careers after watching the video. Subjects who did not see the video through the online campaign were invited to watch the video via a link on the postsurvey. Interest change scores were calculated using differences in Likert-scale responses to the question "how interested are you in a career in clinical research?" An ordinal logistic regression model was used to test the association between watching a peer-shared video, perception of entertainment, and interest change score controlling for underrepresented minorities in medicine status (Black, American Indian/Alaska Native, Native Hawaiian, or Pacific Islander), gender, and baseline interest in medical or clinical research careers. Results: From 2014 to 2017, 325 subjects were enrolled as part of 4 distinct campaigns: #WhereScienceMeetsReality, #RedefiningResearch, #DoYourResearch, and #LifeWithoutResearch. Over half (n=180) of the subjects watched the video via the campaign, 227/295 (76.9%) found the video entertaining, and 92/325 (28.3%) demonstrated baseline interest in clinical research. The ordinal logistic regression model showed that subjects who viewed the video from a peer (odds ratio [OR] 1.56, 95% CI 1.00-2.44, P=.05) or found the video entertaining (OR 1.36, 95% CI 1.01-1.82, P=.04) had greater odds of increasing interest in a clinical research career. Subjects with a higher baseline interest in medicine (OR 1.55, 95% CI 1.28-1.87, P<.001) also had greater odds of increasing their interest in clinical research. Conclusions: The spread of authentic and relevant peer-created messages via social media can increase interest in clinical research careers among diverse teens. Peer-driven social media campaigns should be explored as a way to effectively recruit minority youth into scientific research careers.
What influences trust in and understanding of clinical trials? An analysis of information and communication technology use and online health behavior from the Health Information National Trends Survey

Aurora Occa,Allison S Merritt,Allison Leip,Jerod L Stapleton

DOI: https://doi.org/10.1177/17407745231204813

Abstract:Background: Using information and communication technologies to seek, discuss, and share health-related information influences people's trust and knowledge of several health practices. However, we know little about the associations between individuals' information and communication technology use and their perceptions of trust and knowledge of clinical trials. Examining these associations may lead to the identification of target audiences and channels for developing effective educational interventions and campaigns about clinical trials. Methods: In this study, we analyzed Health Information National Trends Survey data to document perceptions of clinical trial-related knowledge and trust that were recently added as questions in this annual national survey of US adults. We also examined correlates of these clinical trial perceptions that included sociodemographic factors and individuals' use of information and communication technologies to seek health information, discuss such information with their healthcare providers, and share the information in their network. Results: More than 90% of participants had no or limited perceived knowledge about clinical trials. Knowledge was higher among those who seek or discuss health-related information online. Differences in perceived knowledge and trust emerged for some racial/ethnic subgroups and other demographic factors. Providers were considered the most trusted source of information (73.6%), followed by health organizations (19.4%) and social support (7.1%). Trust in health organizations compared to health providers was higher among those who used online resources to share health information online with others. Trust in social support was significantly higher among those who used information and communication technologies to communicate about health. Conclusion: Based on these findings, we recommend developing online resources about clinical trials to be distributed through social media. These resources should facilitate a dialogue and be targeted to several groups considering their information and communication technologies' use.
The Role of Social Media in Enhancing Clinical Trial Recruitment: Scoping Review

Ida Darmawan,Caitlin Bakker,Tabetha A Brockman,Christi A Patten,Milton Eder

DOI: https://doi.org/10.2196/22810

IF: 7.076

2020-10-26

Journal of Medical Internet Research

Abstract:Background Recruiting participants into clinical trials continues to be a challenge, which can result in study delay or termination. Recent studies have used social media to enhance recruitment outcomes. An assessment of the literature on the use of social media for this purpose is required. Objective This study aims to answer the following questions: (1) How is the use of social media, in combination with traditional approaches to enhance clinical trial recruitment and enrollment, represented in the literature? and (2) Do the data on recruitment and enrollment outcomes presented in the literature allow for comparison across studies? Methods We conducted a comprehensive literature search across 7 platforms to identify clinical trials that combined social media and traditional methods to recruit patients. Study and participant characteristics, recruitment methods, and recruitment outcomes were evaluated and compared. Results We identified 2371 titles and abstracts through our systematic search. Of these, we assessed 95 full papers and determined that 33 studies met the inclusion criteria. A total of 17 studies reported enrollment outcomes, of which 9 achieved or exceeded their enrollment target. The proportion of participants enrolled from social media in these studies ranged from 0% to 49%. Across all 33 studies, the proportion of participants recruited and enrolled from social media varied greatly. A total of 9 studies reported higher enrollment rates from social media than any other methods, and 4 studies reported the lowest cost per enrolled participant from social media. Conclusions While the assessment of the use of social media to improve clinical trial participation is hindered by reporting inconsistencies, preliminary data suggest that social media can increase participation and reduce per-participant cost. The adoption of consistent standards for reporting recruitment and enrollment outcomes is required to advance our understanding and use of social media to support clinical trial success.

health care sciences & services,medical informatics
Abstract A007: Expanding clinical trial awareness among Black communities through digital engagement

Eliza B. Cohn,Ryan Huu-Tuan Nguyen,Leslie Carnahan,Kauthar Salum,Neha Hippalgaonkar,Tigist Mersha,Ana Williams,Robbin Block,Kent Hoskins,Vida Henderson

DOI: https://doi.org/10.1158/1538-7755.disp23-a007

2023-12-01

Abstract:Abstract Background: Black patients are less likely to be enrolled in clinical trials compared with White patients, resulting in reduced access to breakthrough treatments and limited understanding of treatment effect. Ineffective dissemination of cancer research, education, and interventions among the public contributes to cancer inequities. Dissemination rarely involves non-research audiences and end-users. We conducted community-engaged research through focus groups with Black community members and family members of cancer survivors. Through these efforts, we are creating a culturally responsive public service announcement (PSA) video to increase clinical trial awareness among Black audiences. Methods: We conducted 5 focus groups over two phases with 1) social support networks of Black cancer survivors (n=20) and 2) Black community members (n=30) to inform the PSA to be disseminated through media and public health outlets. A final focus group will be conducted to elicit video feedback after production. Phase 1 focus groups informed PSA content. Data was triangulated with qualitative data from Black women with breast cancer, oncologists, clinical trial staff, and advocates from a concurrent study about clinical trial participation. Phase 2 focus groups sought feedback on video content prior to production. Content and thematic analyses identified themes and recommendations. Results: For Phases 1 and 2, we used maximum variation sampling to recruit Black participants (n = 50) varied in age, geographic region, education, and gender. Phase 1 themes included: 1) clinical trial mistrust due to experiences of racism persists, but diminishes with younger respondents or those who participated in clinical trials; 2) clinical trial trust-building was associated with transparency from medical experts and information relayed by someone in the Black community and from clinical trial participants; 3) invasive procedures impact views on risks and benefits of participation; 4) messages that are not coercive, but support decision-making are more credible; and 5) sharing the PSA on social media with links to primary resources was recommended. Phase 2 participants reported that the: 1) storyline and script were informative, culturally representative, realistic, and understandable; 2) participants saw themselves in the characters and family dynamics; 3) opening scene should be altered to avoid racial stereotypes; and 4) storyline elicited desire to pursue additional information before making a decision about participation. The script triggered discussion about factors impacting low clinical trial participation and ineffective information dissemination to Black communities. The revised script integrated participant feedback; the video is under production. The PSA is planned to be aired on a national cable network. Conclusions: By eliciting and integrating feedback from Black community members, we developed a culturally representative and responsive PSA that facilitates agency for decision making and information seeking about clinical trials that can be widely disseminated. Citation Format: Eliza B. Cohn, Ryan Huu-Tuan Nguyen, Leslie Carnahan, Kauthar Salum, Neha Hippalgaonkar, Tigist Mersha, Ana Williams, Robbin Block, Kent Hoskins, Vida Henderson. Expanding clinical trial awareness among Black communities through digital engagement [abstract]. In: Proceedings of the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2023 Sep 29-Oct 2;Orlando, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(12 Suppl):Abstract nr A007.

oncology,public, environmental & occupational health
Culturally Tailored Messages and Trial Registry Enrollment

Kevin B. Johnson,Stacy L. Iannone,Susan L. Furth,Lynne Taylor,Andy S. L. Tan

DOI: https://doi.org/10.1001/jamanetworkopen.2024.44229

2024-11-13

JAMA Network Open

Abstract:Importance Marginalized populations have lower levels of clinical trial representation than other populations. Tailoring recruitment materials and providing incentives may improve representation. Objective To determine whether culturally tailored video improves parents' decision to enroll (DTE) Black children in a research registry. Design, Setting, and Participants A randomized clinical trial, using mixed methods and consecutive sampling, was conducted in an urban primary care pediatric clinic. A post hoc study assessed the association of a monetary incentive with DTE. Ninety-three parents were recruited before their child's scheduled clinic visit. Participants completed a survey during which they were randomly assigned to review a paragraph (control group), generic video, or tailored video and received a gift card. Video watchers completed questions about its effectiveness. All participants were invited to join the registry. In the post hoc study, consenting participants followed the control group protocol and the coordinator promised them an ink pen for participating. The study was conducted between November 15, 2022, and August 29, 2023. Intervention A survey regarding the importance of being included in research studies was administered after participants watched a culturally tailored video. Main Outcome and Measures The primary outcome was DTE. Covariates were message effectiveness, clinical trial knowledge, and trust. Intention-to-treat analysis was performed. Results A total of 125 individuals were included. All groups had similar mean (SD) parent age (overall, 32.6 [7.35] years), gender (110 [88.0%] women), and race (116 [92.8%] Black or African American). There was no significant difference in the odds of DTE between the appeal video and control (odds ratio [OR], 1.19; 95% CI, 0.38-3.72) or between the generic video and control (OR, 1.91; 95% CI, 0.54-6.71). However, DTE was higher for all 3 gift card groups vs the ink pen incentive group (eg, control vs ink pen incentive: OR, 5.01; 95% CI, 1.68-14.95). After adjusting for trust, monetary incentives were associated with higher odds of DTE (adjusted OR, 5.92; 95% CI, 2.44-14.39). Conclusions and Relevance In this randomized clinical trial, targeted messaging was not associated with a higher decision to enroll in a pediatric clinical trial registry. There may be a role for combining holistic messaging with monetary incentives to improve enrollment. Trial Registration ClinicalTrials.gov Identifier:NCT06138145

medicine, general & internal
Effects of folic acid on homocysteine in persons classified by methylenetetrahydrofolate reductase genotype.

P. Duell,M. Malinow

DOI: https://doi.org/10.1093/AJCN/69.6.1287

IF: 8.472

1999-06-01

American Journal of Clinical Nutrition

Abstract:Woodside et al (1) recently published an interesting study of the effects of folic acid and vitamins B-6 and B-12 on total plasma homocysteine (tHcy) concentrations in 132 men stratified for the common heat-labile polymorphism [a C-to-T substitution at nucleotide 677 (C677T)] in the gene for methylenetetrahydrofolate reductase (MTHFR). On the basis of results from a subgroup of 50 subjects in this study, the authors concluded that persons who are homozygous (T/T) for the polymorphism are less responsive to the effects of folic acid and B-vitamin supplementation than persons homozygous for the nonthermolabile allele (C/C). They also hypothesized that doses of folic acid > 1 mg/d may be required to reduce plasma tHcy concentrations in the T/T subgroup. These results are in contrast with those from our previous studies of the effects of supplementation with 1 or 2 mg folic acid/d in 242 men and women classified by coronary artery disease status, multivitamin use, and the C677T MTHFR genotype (2). The results of our study, and those of studies by Jacques et al (3) and Deloughery et al (4), suggest that T/T homozygotes are more sensitive to the adverse tHcy-raising effects of reduced plasma folate concentrations. Moreover, our T/T subjects experienced much greater decreases in plasma tHcy concentrations after receiving 1 or 2 mg folic acid/d for 3 wk than did C/C subjects (2). Among subjects who were not previously taking multivitamins, the mean reductions in plasma tHcy concentrations were 220.9%, 213.1%, and 27.1% in persons with the T/T, C/T, and C/C genotypes, respectively (P = 0.019 for T/T compared with C/C; Figure 1). The decreases in plasma tHcy concentrations were not significantly different for subjects receiving 1 compared with 2 mg folic acid/d. Subjects who were previously taking multivitamins experienced smaller decreases in plasma tHcy concentrations after folic acid supplementation, but the T/T homozygotes still showed a trend for greater responsiveness than the C/C or C/T subjects (changes in plasma tHcy concentrations: 210.2%, 23.3%, and 23.2% for T/T, C/T, and C/C genotypes, respectively; NS) (2). Geometric mean plasma tHcy concentrations among T/T, C/T, and C/C subjects were not significantly different after folic acid supplementation. Thus, although individuals with the T/T genotype had higher plasma tHcy concentrations at baseline, our results suggest that these individuals were more sensitive to the tHcy-lowering effects of folic acid supplementation. The reasons for the disparities among the results of these studies are unknown, but additional investigations, including further analyses of the data from Woodside et al, may help to elucidate possible contributory factors.
The FOR US (Fostering Opportunities in Research Using Marketing Strategies) study.

Ryan Huu-Tuan Nguyen,Leslie Carnahan,Eliza Brumer Cohn,Kauthar Salum,Neha Hippalgaonkar,Tigist Mersha,Ana Williams,Robbin Block,Kent Hoskins,Vida Henderson

DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.e18577

IF: 45.3

2023-06-01

Journal of Clinical Oncology

Abstract:e18577 Background: Black patients are less likely to be enrolled in clinical trials compared with White patients, resulting in reduced access to breakthrough treatments and limited understanding of treatment effect in diverse populations. Ineffective dissemination of cancer research, education, and interventions among the public contributes to cancer inequities. Dissemination rarely involves engagement with non-research audiences and end-users. Efforts to promote equity in clinical trial participation may benefit from business marketing strategies traditionally applied in the business sector. Our team is conducting community-engaged research using focus groups with Black community members and family members of cancer survivors, facilitated by a professional marketing agency to create a culturally responsive public service announcement (PSA) video to increase awareness of clinical trials among Black audiences. Methods: We will conduct 6 focus groups over two phases with: 1) social support networks of Black cancer survivors (n = 20, 2 focus groups) and 2) Black community members (n = 40, 4 focus groups) to inform the content and design of a 60 second PSA to be disseminated through media and public health outlets. Phase 1 focus groups will inform content for the PSA. Data will be triangulated with qualitative data from Black patients diagnosed with breast cancer, oncologists, clinical trial staff, and community advocates from a concurrent study. Phase 2 focus groups will garner feedback on video script and style prior to development. Content and thematic analysis approaches will identify themes and PSA recommendations. Results: Phase 1 focus groups (n = 3) are completed. We used maximum variation sampling techniques to recruit Black participants (n = 30) varied in age, geographic location, education, and gender. Themes identified include: 1) mistrust about clinical trials due to past and current experiences of racism persists but diminishes with younger respondents or those with clinical trials; 2) clinical trial trust-building was associated with transparency from medical experts, information from someone in the Black community, and stories from clinical trial participants; 3) invasive procedures (i.e., ingesting or injecting a treatment) are a big factor in weighing the costs and benefits of clinical trial participation; 4) messages that are not coercive, yet support decision-making are more credible; and 5) sharing the PSA on social media with links to primary resources was a favorable dissemination strategy. Next steps are to develop and focus group test creative content and then PSA video production. Conclusions: Applying marketing communication strategies to expand awareness about clinical trial participation among general Black audiences may directly and indirectly facilitate clinical trial participation decision-making processes among Black patients diagnosed with cancer and their support systems.

oncology
Heparin free dialysis: comparative data and results in high risk patients.

Ralph J. Caruana,Rasib M. Raja,Jasmine V. Bush,Mark S. Kramer,Stephen J. Goldstein

DOI: https://doi.org/10.1038/KI.1987.149

IF: 19.6

1987-06-01

Kidney International

Abstract:
Abstract A115: Utilizing digital storytelling to improve the recruitment of Black and Hispanic patients for a genetic predisposition to prostate cancer screening trial

Yi Liu,Brenda Adjei,Anna Couvillon,Kathleen Calzone,Fatima Karzai

DOI: https://doi.org/10.1158/1538-7755.disp24-a115

2024-09-23

Cancer Epidemiology Biomarkers & Prevention

Abstract:Introduction: Clinical genomics leads to more effective cancer prevention, diagnosis, and treatment. Prostate cancer (PC) significantly impacts Black and Hispanic men, but participation in clinical trials and PC risk management methods like genetic testing and screening remains low. Barriers to diversity and inclusion in clinical trials include cultural and socioeconomic factors. Digital storytelling is an effective tool for building trust and increasing community engagement. We aim to develop and assess the use of digital storytelling to improve recruitment of Black and Hispanic patients in a trial for men at high genetic risk for developing PC (clinicaltrials.gov NCT03805919) and raise awareness of genetic testing and enrollment in clinical trials within these communities. Methods: Guided by the Assessing Community Engagement Conceptual Model, we will establish a community advisory panel (CAP) comprised of patient advocates, community, and clinical partners with a strong interest in increasing clinical trial representation of Black and Hispanic patients at high genetic risk for developing PC. CAP participants will be identified from existing partners and through snowballing techniques, which involve asking partners to recommend other CAP participants. The CAP will co-design storytelling interview questions, baseline, and outcome assessments and collectively determine effective methods for digital story dissemination. To evaluate the impact of storytelling on awareness, interest, and participation in genetic testing, medical management, and clinical trial recruitment among Black and Hispanic men, outcome assessments co-designed with the CAP will be administered pre and post-video viewing and include viewer qualitative interviews. Results: Filmed interviews with Black and Hispanic participants will be conducted. Interviews will focus on participant experiences with clinical trials, genetic testing, and cancer risk management. Interview transcripts will be in English and Spanish with forward and back translation to ensure accuracy using National Institutes of Health resources. Local and national partners, community organizations, faith-based institutions, healthcare facilities, and advocacy groups identified by the CAP will facilitate dissemination. Digital stories will be distributed across various multimedia platforms to maximize outreach and accessibility, including community web platforms, social media channels, podcasts, local radio stations, educational workshops, health fairs, cultural events, churches, and support groups. Conclusion: Building strategies for improving patient-centered care delivery and community engagement within culturally diverse populations will enhance clinical trial diversity and inclusion. Using digital storytelling as a recruitment strategy for clinical trials can foster trust, engagement, and participation within Black and Hispanic communities. Study findings will contribute to future clinical trial design and recruitment to enhance underrepresented minority participation in clinical research. Citation Format: Yi Liu, Brenda Adjei, Anna Couvillon, Kathleen Calzone, Fatima Karzai. Utilizing digital storytelling to improve the recruitment of Black and Hispanic patients for a genetic predisposition to prostate cancer screening trial [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr A115.

oncology,public, environmental & occupational health
Understanding how nurses can effectively utilise social media for increasing public involvement, recruitment and impact dissemination of Clinical Research Trials

Jessica Eve Jackson,Joshua Moreton,Nicola Barnett,Matthew Hurst

DOI: https://doi.org/10.1177/17449871241246963

Abstract:Background: The methodologies for clinical research trials are evolving to greater usage of social media platforms, providing opportunities to incorporate smart technologies in their delivery. Research Nurses should consider how they can utilise platforms for public engagement in trials. Aim: To explore the experiences of social media platforms and clinical research trials in a healthy population group, to gain insight into how clinical researchers can utilise these platforms professionally and ethically. Methods: Using a critical realist qualitative focus group design with template analysis, we recruited 16 healthy members of the public aged 18-75 years. The data expands upon their thoughts and behaviours regarding social media platforms with their understanding of clinical research. Results: Three main themes along with their specific subthemes (1) Design: Patient and Public Involvement (Subtheme: Understanding of clinical research, Diversity of social media users), (2) Implementation: Recruitment to active studies, (Subtheme: Motivators for volunteering, Trustworthy), (3) Dissemination: Impact and Awareness of Results, (Subtheme: Information overload, Motivations for users to share information). Conclusions: This study has highlighted the need to consider the way different population groups use social media platforms and the information they share when looking to engage them in clinical research trials.
Digital technologies used in clinical trial recruitment and enrollment including application to trial diversity and inclusion: A systematic review

Amy Kasahara,Jennifer Mitchell,Joshua Yang,Raphael E. Cuomo,Tiana J. McMann,Tim K. Mackey

DOI: https://doi.org/10.1177/20552076241242390

2024-01-01

Digital Health

Abstract:Background Many clinical trials fail because of poor recruitment and enrollment which can directly impact the success of biomedical and clinical research outcomes. Options to leverage digital technology for improving clinical trial management are expansive, with potential benefits for improving access to clinical trials, encouraging trial diversity and inclusion, and potential cost-savings through enhanced efficiency. Objectives This systematic review has two key aims: (1) identify and describe the digital technologies applied in clinical trial recruitment and enrollment and (2) evaluate evidence of these technologies addressing the recruitment and enrollment of racial and ethnic minority groups. Methods We conducted a cross-disciplinary review of articles from PubMed, IEEE Xplore, and ACM Digital Library, published in English between January 2012 and July 2022, using MeSH terms and keywords for digital health, clinical trials, and recruitment and enrollment. Articles unrelated to technology in the recruitment/enrollment process or those discussing recruitment/enrollment without technology aspects were excluded. Results The review returned 614 results, with 21 articles (four reviews and 17 original research articles) deemed suitable for inclusion after screening and full-text review. To address the first objective, various digital technologies were identified and characterized, which included articles with more than one technology subcategory including (a) multimedia presentations (19%, n = 4); (b) mobile applications (14%, n = 3); (c) social media platforms (29%, n = 6); (d) machine learning and computer algorithms (19%, n = 4); (e) e-consenting (24%, n = 5); (f) blockchain (5%, n = 1); (g) web-based programs (24%, n = 5); and (h) virtual messaging (24%, n = 5). Additionally, subthemes, including specific diseases or conditions addressed, privacy and regulatory concerns, cost/benefit analyses, and ethnic and minority recruitment considerations, were identified and discussed. Limited research was found to support a particular technology's effectiveness in racial and ethnic minority recruitment and enrollment. Conclusion Results from this review illustrate that several types of technology are currently being explored and utilized in clinical trial recruitment and enrollment stages. However, evidence supporting the use of digital technologies is varied and requires further research and evaluation to identify the most valuable opportunities for encouraging diversity in clinical trial recruitment and enrollment practices.

public, environmental & occupational health,health care sciences & services,medical informatics,health policy & services
[Psychometric speech studies in Alzheimer's dementia with the Aachen aphasia test].

C. Lang,E. Bozikake-Leisch,M. Spambalg,P. Bartelsen,T. Treig

1991-10-01

Der Nervenarzt

Abstract:Dementias of the Alzheimer type seem to be frequently accompanied by language disturbances. These may represent a feature which can be of help in distinguishing them from other types of dementias. We used the Aachen aphasia test in 32 patients suffering from Alzheimer dementia according to research criteria, and a mixed sample of 35 patients suffering from other dementias. From these 2 groups 2 subsamples of 21 patients each were gathered which were comparable with regard to age, disease onset, level of education, verbal intelligence and severity of senility. Nevertheless it was possible to distinguish the groups to a certain degree on grounds of psychometric language criteria alone. Alzheimer patients were more severely handicapped communicatively, less dysarthric, produced more automatisms and discretely more phonemic paraphasias with fluent speech which was sometimes paragrammatic. A relatively better level of repetition compared to the Token test and written language was fairly specific. A computer-assisted classification yielded language disturbances similar to Wernicke's aphasia more often than with non-Alzheimer dementias. We found no Alzheimer patients with a Broca's type of language disorder, while amnestic and global types were bound to the level of overall impairment to a certain degree. The significance of these results with regard to the use of psychometric language test in the dementias, particularly Alzheimer's dementia, and to differential diagnostic considerations are reviewed briefly.
Abstract A107: Be Part of the Cure Clinical Trials Campaign: Koreans, Hispanic/Latino/a/e/x, and Black/African Americans living in Los Angeles County

Ghecemy Lopez,Dong Hee Kim,Zul Surani,Lourdes Barajas

DOI: https://doi.org/10.1158/1538-7755.disp24-a107

2024-09-23

Cancer Epidemiology Biomarkers & Prevention

Abstract:Background. There is negative perception and lack of participation in clinical trials among Koreans, Hispanic/Latino/a/e/x, and Black/African Americans living in Los Angeles County, which may be attributed to cultural beliefs, language barriers, historical mistrust of medical research, and lack of awareness about the benefits of participation. Without representation from diverse groups, there may be missed opportunities to develop personalized treatment approaches tailored to specific genetic, cultural, and lifestyle factors. Methods. Cedars Sinai Cancer Community Outreach and Engagment (COE) developed a multi-level approach to increase representation of minority populations in clinical trials. With active Community Advisory Board involvement in the development and implementation, a culturally sensitive clinical trials awareness campaign, "Be Part of the Cure", was developed to offer in-language cancer information, education on clinical trials, and navigation through the cancer care continuum. To support patients and facilitate access to trials, COE has developed bi-directional engagement between CCSC physicians, nurses and Clinical Trials Office representatives, FQHCs, and community and faith-based organizations to ensure a seamless navigation process to care. Additionally, our multicultural and multilingual COE staff have trained Community Health Workers and navigators to expand our outreach efforts and effectively engage our target communities. Results. In total, COE has facilitated 7 health education workshops and attended 3 community outreach events with 501 people educated (37% or 184 Black/African American; 25% or 123 Asians; 17% or 87 Hispanic/Latinx; and 21% or 107 White). Pre/post-tests administered to 73 Koreans during health education workshops showed significant increase in positive perception on clinical trials from 57% to 95%. Korean (n=9) cancer patients have expressed interest in clinical trials, and 1 have been enrolled in Neoadjuvant HER2-Targeted Therapy and Immunotherapy with Pembrolizumab clinical trial. Among Hispanic/Latinx/a/o community, 1 clinical trials health awareness workshop was convened with clinicians who presented to promotores, patients, caregivers, survivors and community members. There were 25 people who completed the pre/post test. There was an increase in positive perception on clinical trials from 52% to 100%, willingness to participate from 60% to 96%, and likelihood of encouraging others to participate from 60% to 96%. In the Black/African American community, 1 clinical trials health awareness workshop was also convened. Among attendees, 21 people completed Pre/Post Test and positive perception on clincal trials increased from 47% to 85%, willingness to participate from 43% to 81%, and likehood on encouraging others to participate from 52% to 81%. Conclusion. Efforts to increase diversity and inclusion in clinical trials should focus on culturally sensitive recruitment strategies, language accessibility, community engagement, and building trust between researchers and communities. Citation Format: Ghecemy Lopez, Dong Hee Kim, Zul Surani, Lourdes Barajas. Be Part of the Cure Clinical Trials Campaign: Koreans, Hispanic/Latino/a/e/x, and Black/African Americans living in Los Angeles County [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr A107.

oncology,public, environmental & occupational health
Digitizing clinical trials

O T Inan,P Tenaerts,S A Prindiville,H R Reynolds,D S Dizon,K Cooper-Arnold,M Turakhia,M J Pletcher,K L Preston,H M Krumholz,B M Marlin,K D Mandl,P Klasnja,B Spring,E Iturriaga,R Campo,P Desvigne-Nickens,Y Rosenberg,S R Steinhubl,R M Califf

DOI: https://doi.org/10.1038/s41746-020-0302-y

2020-07-31

Abstract:Clinical trials are a fundamental tool used to evaluate the efficacy and safety of new drugs and medical devices and other health system interventions. The traditional clinical trials system acts as a quality funnel for the development and implementation of new drugs, devices and health system interventions. The concept of a "digital clinical trial" involves leveraging digital technology to improve participant access, engagement, trial-related measurements, and/or interventions, enable concealed randomized intervention allocation, and has the potential to transform clinical trials and to lower their cost. In April 2019, the US National Institutes of Health (NIH) and the National Science Foundation (NSF) held a workshop bringing together experts in clinical trials, digital technology, and digital analytics to discuss strategies to implement the use of digital technologies in clinical trials while considering potential challenges. This position paper builds on this workshop to describe the current state of the art for digital clinical trials including (1) defining and outlining the composition and elements of digital trials; (2) describing recruitment and retention using digital technology; (3) outlining data collection elements including mobile health, wearable technologies, application programming interfaces (APIs), digital transmission of data, and consideration of regulatory oversight and guidance for data security, privacy, and remotely provided informed consent; (4) elucidating digital analytics and data science approaches leveraging artificial intelligence and machine learning algorithms; and (5) setting future priorities and strategies that should be addressed to successfully harness digital methods and the myriad benefits of such technologies for clinical research.
UREA-CREATININE RATIO IN OBSTRUCTIVE UROPATHY AND RENAL HYPERTENSION.

S. Marshall

DOI: https://doi.org/10.1001/JAMA.1964.03070210025004

1964-11-23

Abstract:An elevated ratio of blood urea nitrogen to serum creatinine was found in patients with severe urinary tract obstruction, and a lower ratio of urinary urea to creatinine was found in cases of renal ischemia. These findings are believed to be secondary, for the most part, to the slowing of the flow of urine through the renal tubule, with a resultant greater reabsorption of urea; this slowing, with obstruction, is from hydrostatic back pressure and, with renal ischemia, from a decrease in glomerular filtration rate. These ratios may be of practical value both in determining the relative role of obstruction in cases of impaired renal function and in differential function studies for renal hypertension.
“There was No Opportunity to Express Good or Bad”: Perspectives From Patient Focus Groups on Patient Experience in Clinical Trials

Patrick Boyd,Elizabeth A Sternke,David J Tite,Kristopher Morgan

DOI: https://doi.org/10.1177/23743735241237684

2024-01-01

Journal of Patient Experience

Abstract:To understand how patients perceive their experiences leading up to, during, and after a clinical trial, and the relationship these experiences had with future willingness to participate, we conducted 3 focus groups with patients who had prior clinical trial involvement (n = 25). Discussion topics included clinical trial discovery, enrollment, communication, trust, patient-centricity, and future enrollment. Patient focus groups revealed a variety of motivations for enrolling in clinical trials (eg, altruism, efficacious treatment, curiosity, desperation, etc.). Patients learned about clinical trials through trusted sources (eg, primary care physicians, patient advocacy groups) and social media. Access and uncertainty about clinical trials were barriers to enrollment. Patient-centric communication and attention given to disease states and symptom severity were valued and made patients feel genuinely cared about. Post-trial follow up and being informed of trial results were inconsistently reported by patients. Critically, patients described frustration with an overall lack of patient experience measurement. Patients identified a need to measure experiences before, during, and after clinical trials and emphasized that doing so would facilitate patient trust and overall experience.
Abstract A064: My Choices: A multilevel, multicomponent intervention to improve informed decision-making about clinical trial participation among cancer patients

Patricia Chalela,Vivian Cortez,Armida Flores,Sandra Sivak,Edgar Munoz,Cliff Despres,Callie Rainosek,Alyssa Gonzalez,Mio Kitano,Virginia Kaklamani,Kate Lathrop,Sukeshi Arora,Andrew Brenner,Deepak K. Pruthi,Amelie G. Ramirez

DOI: https://doi.org/10.1158/1538-7755.disp23-a064

2023-12-02

Cancer Epidemiology Biomarkers & Prevention

Abstract:Background: Knowledge gained through cancer clinical trials (CTs) has been proven critical to preventing, diagnosing and treating the disease, and providing the evidence base for clinical practice. Major advances in cancer treatment, which are essential for improving patients' outcomes, come from investigations of new therapeutic agents in CTs. Despite the large number of available studies and improvements in public awareness about CTs, participation of underrepresented minorities in clinical research has been persistently low, with only 2-5% of Latinos and African Americans participating in cancer treatment trials. Barriers to participation are multilevel, complex, and multifactorial, including study design, healthcare system barriers, and patient- and medical team-related factors. Structural inequities, social determinants of health (SDoH), distrust of government, patient-doctor communications, cultural and language barriers, and lower levels of health literacy are barriers for Latino and African American populations. Purpose: To improve informed decision-making about cancer CT participation among cancer patients and community members through a bilingual multilevel, multi-communication approach, including: 1) a 2-group parallel randomized controlled educational trial, and 2) a community awareness campaign. Methods: The randomized study involves 400 patients from the Mays Cancer Center. The intervention group receives 1) a bilingual educational video on CTs with patients' testimonials, 2) a low literacy booklet, 3) support from a patient navigator (PN), and 4) Salud America! weekly emails with links to online/social media posts on CT. The control group receives a general fact sheet on CTs. Healthcare providers involved in clinical research are invited to participate in Webinars to raise awareness of implicit bias and the importance of inclusive research. The community intervention features a prospective single-group pre/post design, where participants (400) act as their own controls. They receive an educational session on CTs provided by a community health educator + a low literacy booklet. Results: Focus groups guided the development of the video script, booklet, and educational materials. The short video features real cancer patients sharing their experiences with CTs and how they overcame common barriers. Study recruitment began in February 2023. So far, we have recruited 36 cancer patients with a mean age of 51 years, 80% White and 61% Hispanic/Latino, 64% married, 44% had Medicare/Medicaid; 36% < high school education; and 33% earned <$40K. Preliminary results will be presented. Conclusions: Multilevel interventions involving culturally tailored decision aids (i.e., video, booklet) in combination with PN support can effectively address common barriers influencing patient decision-making, raise awareness of CTs, and increase positive attitudes, intentions, and participation in CTs among groups experiencing SDoH. Citation Format: Patricia Chalela, Vivian Cortez, Armida Flores, Sandra Sivak, Edgar Munoz, Cliff Despres, Callie Rainosek, Alyssa Gonzalez, Mio Kitano, Virginia Kaklamani, Kate Lathrop, Sukeshi Arora, Andrew Brenner, Deepak K. Pruthi, Amelie G. Ramirez. My Choices: A multilevel, multicomponent intervention to improve informed decision-making about clinical trial participation among cancer patients [abstract]. In: Proceedings of the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2023 Sep 29-Oct 2;Orlando, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(12 Suppl) nr A064.

oncology,public, environmental & occupational health
Promotion of Knowledge and Trust Surrounding Scarce Resource Allocation Policies: A Randomized Clinical Trial

Russell G Buhr,Ruby Romero,Lauren E Wisk

DOI: https://doi.org/10.1001/jamahealthforum.2024.3509

2024-10-04

JAMA Health Forum

Abstract:Importance: The COVID-19 pandemic prompted rapid development of scarce resource allocation policies (SRAPs) in case demand for critical health services eclipsed capacity. Objective: To test whether a brief educational video could improve knowledge of how the University of California Health's SRAP would be implemented and trust in health systems to implement such policies in accordance with ethical principles during the pandemic. Design, setting, and participants: This randomized clinical trial used an educational video intervention embedded in a longitudinal web-based survey and was conducted between May and December 2020 and analyzed during March 2024. A total of 1971 adult participants were enrolled, of whom 939 completed follow-up; participants with matched baseline and follow-up responses were analyzed. California residents were randomized to view the intervention (n = 345) or not (n = 353) and stratified by age, sex, education, racial identity, and self-reported health care worker status. Non-California residents were allocated to the control group (n = 241). Interventions: A brief (6-minute) "explainer" video that provided an overview of mechanics and ethical principles underpinning the University of California Health SRAP, subtitled in 6 languages. Main outcomes and measures: Self-reported survey assessment of knowledge of components of SRAP, graded as correct vs incorrect, and trust graded on a 10-point Likert scale. Anxiety about such policies was graded on a 10-point Likert scale with an a priori noninferiority margin of half of a standard deviation. Participants answered items at baseline and follow-up (approximately 10 weeks after baseline), with randomization occurring between administrations. Results: Of 770 randomized participants with responses at both points, 566 (73.5%) were female, and the median (IQR) age was 43.5 (36-57) years. Intervention participants demonstrated improvement of 5.6 (95% CI, 4.8-6.4; P < .001) more correct knowledge items of 20 vs controls, as well as significant improvements in reported trust in fairness/consistency and honesty/transparency about SRAP implementation. There was no significant change in reported anxiety surrounding SRAP in either treatment or control groups. Conclusions and relevance: The trial found that a brief educational video is sufficient to explain complex ethical tenets and mechanics of SRAP and improved knowledge of such policies and trust in health systems to implement them equitably while not exacerbating anxiety about potential policy implications. This informs practice by providing a framework for educating people about the use of these policies during future situations necessitating crisis standards of care. Trial registration: ClinicalTrials.gov Identifier: NCT04373135.

Transition probability calculations for atoms using nonorthogonal orbitals.

Elastic Stiffness of the Nuclear-Spin System in Tetragonal U 2 D 2 Nuclear-Ordered Solid 3

"Trust Me, I'm a Doctor." How TikTok Videos from Different Sources Influence Clinical Trial Participation

A Peer-Led Social Media Intervention to Improve Interest in Research Careers Among Urban Youth: Mixed Methods Study

What influences trust in and understanding of clinical trials? An analysis of information and communication technology use and online health behavior from the Health Information National Trends Survey

The Role of Social Media in Enhancing Clinical Trial Recruitment: Scoping Review

Abstract A007: Expanding clinical trial awareness among Black communities through digital engagement

Culturally Tailored Messages and Trial Registry Enrollment

Effects of folic acid on homocysteine in persons classified by methylenetetrahydrofolate reductase genotype.

The FOR US (Fostering Opportunities in Research Using Marketing Strategies) study.

Heparin free dialysis: comparative data and results in high risk patients.

Abstract A115: Utilizing digital storytelling to improve the recruitment of Black and Hispanic patients for a genetic predisposition to prostate cancer screening trial

Understanding how nurses can effectively utilise social media for increasing public involvement, recruitment and impact dissemination of Clinical Research Trials

Digital technologies used in clinical trial recruitment and enrollment including application to trial diversity and inclusion: A systematic review

[Psychometric speech studies in Alzheimer's dementia with the Aachen aphasia test].

Abstract A107: Be Part of the Cure Clinical Trials Campaign: Koreans, Hispanic/Latino/a/e/x, and Black/African Americans living in Los Angeles County

Digitizing clinical trials

UREA-CREATININE RATIO IN OBSTRUCTIVE UROPATHY AND RENAL HYPERTENSION.

“There was No Opportunity to Express Good or Bad”: Perspectives From Patient Focus Groups on Patient Experience in Clinical Trials

Abstract A064: My Choices: A multilevel, multicomponent intervention to improve informed decision-making about clinical trial participation among cancer patients

Promotion of Knowledge and Trust Surrounding Scarce Resource Allocation Policies: A Randomized Clinical Trial